Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplantation (FMT) in recipients after allogeneic hematopoietic cell transplantation (HCT) has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Cell Transplantation Recipient Outcomes or Complications Not Disease Per Se But Associated Conditions Such As Graft-versus-host Disease May Be Involved

Snippet

Sponsor: Zachariah Michael DeFilipp | Conditions: Allogeneic Hematopoietic Cell Transplantation (HCT) | Phase 2 | Status: TERMINATED | Results posted: 2021-12-01